These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30968766)

  • 1. 2,4-Thiazolidinediones as PTP 1B Inhibitors: A Mini Review (2012-2018).
    Verma SK; Yadav YS; Thareja S
    Mini Rev Med Chem; 2019; 19(7):591-598. PubMed ID: 30968766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus.
    Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
    Med Res Rev; 2012 May; 32(3):459-517. PubMed ID: 20814956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
    Verma M; Gupta SJ; Chaudhary A; Garg VK
    Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-QSAR studies on a series of 2,4-thiazolidinedione derivatives: a self- organizing molecular field analysis approach to design novel PTP 1B inhibitors.
    Malla P; Kumar M
    Med Chem; 2013 Sep; 9(6):828-45. PubMed ID: 22974292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
    Hidalgo-Figueroa S; Estrada-Soto S; Ramírez-Espinosa JJ; Paoli P; Lori G; León-Rivera I; Navarrete-Vázquez G
    Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
    Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
    Wang Z; Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3337-40. PubMed ID: 24953600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity.
    Rocha RF; Rodrigues T; Menegatti ACO; Bernardes GJL; Terenzi H
    Bioorg Chem; 2020 Jul; 100():103927. PubMed ID: 32422389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
    Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
    Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
    Mahapatra MK; Kumar R; Kumar M
    Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-organizing molecular field analysis of 2,4-thiazolidinediones: A 3D-QSAR model for the development of human PTP1B inhibitors.
    Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
    Eur J Med Chem; 2010 Jun; 45(6):2537-46. PubMed ID: 20236737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of paracaseolide A analogues as selective protein tyrosine phosphatase 1B inhibitors.
    Yin JP; Tang CL; Gao LX; Ma WP; Li JY; Li Y; Li J; Nan FJ
    Org Biomol Chem; 2014 Jun; 12(21):3441-5. PubMed ID: 24752625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of protein tyrosine phosphatase (PTP-1B) in insulin resistance].
    Boduła A; Wdowczyk M; Adamiec R
    Postepy Hig Med Dosw (Online); 2005 May; 59():203-7. PubMed ID: 15928604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone attenuates tumor necrosis factor-α-induced protein-tyrosine phosphatase-1B production in HepG2 cells.
    Wu J; Yang LJ; Zou DJ
    J Endocrinol Invest; 2012 Jan; 35(1):28-34. PubMed ID: 21483233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes.
    Qian S; Zhang M; He Y; Wang W; Liu S
    Future Med Chem; 2016 Jul; 8(11):1239-58. PubMed ID: 27357615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1B.
    Ong JX; Yap CW; Ang WH
    Inorg Chem; 2012 Nov; 51(22):12483-92. PubMed ID: 23121648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors.
    Biharee A; Singh Y; Kulkarni S; Jangid K; Kumar V; Jain AK; Thareja S
    J Mol Graph Model; 2024 Mar; 127():108695. PubMed ID: 38118354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-Tyrosine Phosphatase-1B Mediates Sleep Fragmentation-Induced Insulin Resistance and Visceral Adipose Tissue Inflammation in Mice.
    Gozal D; Khalyfa A; Qiao Z; Akbarpour M; Maccari R; Ottanà R
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28651353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationship (QSAR) and design of novel ligands that demonstrate high potency and target selectivity as protein tyrosine phosphatase 1B (PTP 1B) inhibitors as an effective strategy used to model anti-diabetic agents.
    Arthur DE; Ejeh S; Uzairu A
    J Recept Signal Transduct Res; 2020 Dec; 40(6):501-520. PubMed ID: 32397858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.